Document is current

Any future updates will be listed below

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives

Crossref DOI link: https://doi.org/10.1007/s00432-017-2407-5

Published Online: 2017-04-12

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark